Sort   by:  
 Page size 
UnknownImpacts of Adaptive Statistical Iterative Reconstruction-V and Deep Learning Image Reconstruction Algorithms on Robustness of CT Radiomics Features: Opportunity for Minimizing Radiomics Variability Among Scans of Different Dose Levels.
Not available
S-EPMC10976956 | biostudies-literature
UnknownRobustness of radiomics features of virtual unenhanced and virtual monoenergetic images in dual-energy CT among different imaging platforms and potential role of CT number variability.
Not available
S-EPMC10175529 | biostudies-literature
ProteomicsQuantitative proteomics during anthers development in Oryza longistaminata
Tandem mass tags (TMT)-based quantitative analysis was used to investigate the profiles of proteins related to lipid and carbohydrate metabolism in 4-, 6- and 8.5-mm O. longistaminata spikelets before flowering. O. longistaminata plants were sampled at three important stages of pollen development: 4...
ORGANISM(S): Oryza longistaminata 
2022-02-16 | PXD028805 | Pride
Oryza longistaminata  pollen viability  proteome 
UnknownRobustness of CT radiomics features: consistency within and between single-energy CT and dual-energy CT.
Not available
S-EPMC9279234 | biostudies-literature
ProteomicsA proteomic analysis of plasma using data-independent acquisition approach to explore infantile epileptic spasm syndrome
Infantile epileptic spasm syndrome (IESS) presents a significant challenge in pediatric neurology due to its potential for progressive cognitive and behavioral impairments. This study aimed to shed light on the pathogenesis of IESS through a comprehensive proteomic analysis of plasma samples using d...
ORGANISM(S): Homo Sapiens 
2024-05-22 | PXD052465 |
ProteomicsProteomics of Esophageal Squamous Cell Carcinoma Response to anti-PD1 Immunotherapy Response
Immunotherapy has revolutionized cancer treatment, yet many patients do not respond. Here, we profile the proteome and phosphoproteome of clinical pre-treatment samples from 73 esophageal squamous cell carcinoma (ESCC) patients undergoing anti-programmed death 1 (PD1) immunotherapy.
ORGANISM(S): Homo Sapiens 
2026-03-31 | PXD076423 |
Sort   by:  
 Page size